Association of reduced glyoxalase 1 activity and painful peripheral diabetic neuropathy in type 1 and 2 diabetes mellitus patients

Journal of Diabetes and its Complications

Volumn 27, Issue 3, 2013, Pages 262-267

  Skapare, Elina ^a,b   Konrade, Ilze ^a,d   Liepinsh, Edgars ^a   Strele, Ieva ^b   Makrecka, Marina ^a,b   Bierhaus, Angelika ^c   Lejnieks, Aivars ^d   Pirags, Valdis ^e   Dambrova, Maija ^a,b  

^a LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

^b RIGA STRADINS UNIVERSITY   (Latvia)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d RIGA EAST UNIVERSITY HOSPITAL   (Latvia)

^e UNIVERSITY OF LATVIA   (Latvia)

Author keywords

Diabetes mellitus; Glyoxalase 1; Painful diabetic neuropathy; Type 1 diabetes; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; C PEPTIDE; GLYOXALASE; GLYOXALASE 1; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTIHYPERTENSIVE THERAPY; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DISEASE ASSOCIATION; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; DISEASE PROGRESSION; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LACTOYLGLUTATHIONE LYASE; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; SEVERITY OF ILLNESS INDEX;

EID: 84876937363     PISSN: 10568727     EISSN: 1873460X     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2012.12.002     Document Type: Article

References (37)

1. American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 30 2007 42 47
2. F. Arnalich, A. Hernanz, D. Lopez-Maderuelo, J.M. Pena, J. Camacho, and R. Madero Enhanced acute-phase response and oxidative stress in older adults with type II diabetes Hormone and Metabolic Research 32 2000 407 412
3. A. Bierhaus, T. Fleming, S. Stoyanov, A. Leffler, A. Babes, and C. Neacsu Methylglyoxal modification of Na(v)1.8 facilitates nociceptive neuron firing and causes hyperalgesia in diabetic neuropathy Nature Medicine 18 2012 926 933
4. A.J. Boulton, A.I. Vinik, J.C. Arezzo, V. Bril, E.L. Feldman, and R. Freeman Diabetic neuropathies: a statement by the American Diabetes Association Diabetes Care 28 2005 956 962
5. M.A. Cotter, A.M. Jack, and N.E. Cameron Effects of the protein kinase C beta inhibitor LY333531 on neural and vascular function in rats with streptozotocin-induced diabetes Clinical Science (London) 103 2002 311 321
6. M. Dobretsov, S.L. Hastings, D. Romanovsky, J.R. Stimers, and J.M. Zhang Mechanical hyperalgesia in rat models of systemic and local hyperglycemia Brain Research 960 2003 174 183
7. J. Doupis, T.E. Lyons, S. Wu, C. Gnardellis, T. Dinh, and A. Veves Microvascular reactivity and inflammatory cytokines in painful and painless peripheral diabetic neuropathy The Journal of Clinical Endocrinology and Metabolism 94 2009 2157 2163
8. B. Duran-Jimenez, D. Dobler, S. Moffatt, N. Rabbani, C.H. Streuli, and P.J. Thornalley Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes Diabetes 58 2009 2893 2903
9. S.E. Eaton, N.D. Harris, S. Ibrahim, K.A. Patel, F. Selmi, and M. Radatz Increased sural nerve epineurial blood flow in human subjects with painful diabetic neuropathy Diabetologia 46 2003 934 939
10. C. Herder, M. Lankisch, D. Ziegler, W. Rathmann, W. Koenig, and T. Illig Subclinical inflammation and diabetic polyneuropathy: MONICA/KORA Survey F3 (Augsburg, Germany) Diabetes Care 32 2009 680 682
11. N. Hotta, K. Yasuda, Y. Sumita, T. Sano, H. Kakuta, and M. Nagashima Effects of a Novel Aldose Reductase Inhibitor, Fidarestat (SNK-860), on Vibration Perception Threshold and Subjective Symptoms in Patients with Diabetic Polyneuropathy: An Open-Label Pilot Study Clinical Drug Investigation 24 2004 671 680
12. M.M. Jack, J.M. Ryals, and D.E. Wright Characterisation of glyoxalase I in a streptozocin-induced mouse model of diabetes with painful and insensate neuropathy Diabetologia 54 2011 2174 2182
13. A.J. Jenkins, M. Rothen, R.L. Klein, K. Moller, L. Eldridge, and D. Zheng Cross-sectional associations of C-reactive protein with vascular risk factors and vascular complications in the DCCT/EDIC cohort Journal of Diabetes and its Complications 22 2008 153 163
14. N. Karachalias, R. Babaei-Jadidi, N. Rabbani, and P.J. Thornalley Increased protein damage in renal glomeruli, retina, nerve, plasma and urine and its prevention by thiamine and benfotiamine therapy in a rat model of diabetes Diabetologia 53 2010 1506 1516
15. A. McIntosh, J. Peters, R. Young, A. Hutchinson, R. Chiverton, and S. Clarkson Prevention and Management of Foot Problems in Type 2 diabetes: Clinical Guidelines and Evidence 2003 School of Health and Related Research (ScHARR), University of Sheffield Sheffield
16. A.C. McLellan, P.J. Thornalley, J. Benn, and P.H. Sonksen Glyoxalase system in clinical diabetes mellitus and correlation with diabetic complications Clinical Science (London) 87 1994 21 29
17. I.G. Obrosova, V.R. Drel, C.L. Oltman, N. Mashtalir, J. Tibrewala, and J.T. Groves Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats American Journal of Physiology. Endocrinology and Metabolism 293 2007 1645 1655
18. I.G. Obrosova, W. Xu, V.V. Lyzogubov, O. Ilnytska, N. Mashtalir, and I. Vareniuk PARP inhibition or gene deficiency counteracts intraepidermal nerve fiber loss and neuropathic pain in advanced diabetic neuropathy Free Radical Biology & Medicine 44 2008 972 981
19. C. Quattrini, N.D. Harris, R.A. Malik, and S. Tesfaye Impaired skin microvascular reactivity in painful diabetic neuropathy Diabetes Care 30 2007 655 659
20. N. Rabbani, and P.J. Thornalley Methylglyoxal, glyoxalase 1 and the dicarbonyl proteome Amino Acids 42 2012 1133 1142
21. K.M. Ramos, Y. Jiang, C.I. Svensson, and N.A. Calcutt Pathogenesis of spinally mediated hyperalgesia in diabetes Diabetes 56 2007 1569 1576
22. D.M. Ratliff, D.J. Vander Jagt, R.P. Eaton, and D.L. Vander Jagt Increased levels of methylglyoxal-metabolizing enzymes in mononuclear and polymorphonuclear cells from insulin-dependent diabetic patients with diabetic complications: aldose reductase, glyoxalase I, and glyoxalase II-a clinical research center study The Journal of Clinical Endocrinology and Metabolism 81 1996 488 492
23. D. Selvarajah, I.D. Wilkinson, C.J. Emery, P.J. Shaw, P.D. Griffiths, and R. Gandhi Thalamic neuronal dysfunction and chronic sensorimotor distal symmetrical polyneuropathy in patients with type 1 diabetes mellitus Diabetologia 51 2008 2088 2092
24. S.R. Sharma, and N. Sharma Epalrestat, an aldose reductase inhibitor, in diabetic neuropathy: an Indian perspective Annals of Indian Academy of Neurology 11 2008 231 235
25. R. Sharma-Luthra, and R.K. Kale Age related changes in the activity of the glyoxalase system Mechanisms of Ageing and Development 73 1994 39 45
26. E. Skapare, U. Riekstina, E. Liepinsh, I. Konrade, M. Makrecka, and B. Maurina Flow cytometric analysis of glyoxalase-1 expression in human leukocytes Cell Biochemistry and Function 29 2011 171 174
27. S. Tesfaye, and D. Selvarajah Advances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy Diabetes/Metabolism Research and Reviews 28 2012 8 14
28. The Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus The New England Journal of Medicine 329 1993 977 986
29. P.J. Thornalley Modification of the glyoxalase system in human red blood cells by glucose in vitro The Biochemical Journal 254 1988 751 755
30. P.J. Thornalley Glutathione-dependent detoxification of alpha-oxoaldehydes by the glyoxalase system: involvement in disease mechanisms and antiproliferative activity of glyoxalase I inhibitors Chemico-Biological Interactions 111-112 1998 137 151
31. P.J. Thornalley Glyoxalase I-structure, function and a critical role in the enzymatic defence against glycation Biochemical Society Transactions 31 2003 1343 1348
32. P.J. Thornalley Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems-role in ageing and disease Drug Metabolism and Drug Interactions 23 2008 125 150
33. P.J. Thornalley, N.I. Hooper, P.E. Jennings, C.M. Florkowski, A.F. Jones, and J. Lunec The human red blood cell glyoxalase system in diabetes mellitus Diabetes Research and Clinical Practice 7 1989 115 120
34. P.J. Thornalley, A.C. McLellan, T.W. Lo, J. Benn, and P.H. Sonksen Negative association between erythrocyte reduced glutathione concentration and diabetic complications Clinical Science (London) 91 1996 575 582
35. UK Prospective Diabetes Study (UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) The Lancet 352 1998 837 853
36. M.J. Young, A.J. Boulton, A.F. MacLeod, D.R. Williams, and P.H. Sonksen A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population Diabetologia 36 1993 150 154
37. D. Ziegler, H. Nowak, P. Kempler, P. Vargha, and P.A. Low Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis Diabetic Medicine 21 2004 114 121